| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
JD Stategies is a Los Altos, CA-based company in the Software and Internet sector.
Pointivity is one of the leading providers in Software and Internet. It is based in San Diego, CA. To find more information about Pointivity, please visit www.pointivity.com.
Login VSI provides predictive and advanced insights for virtualized desktop and server based computing environments. Our software ensures Enterprises can provide their employees with the best end-user experience. By utilizing virtual users that mimic r...